CX3CR1: a potential microglia-specific PET imaging target in Alzheimer's and Parkinson's diseases
Hongzhi Yang1, Yanli Wang2, Yulong Xu2
1Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Abstract:
Microglia are the resident immune cells of the central nervous system (CNS), playing a crucial role in maintaining brain homeostasis and mediating neuroimmune responses. The chemokine receptor CX3CR1, predominantly expressed on microglia, regulates microglial function via interactions with its neuronal ligand CX3CL1. The CX3CR1-CX3CL1 signaling exhibits complex, context-dependent roles in neurodegenerative diseases. In Alzheimer's disease (AD) and Parkinson's disease (PD) animal models, CX3CR1 deficiency shows paradoxical outcomes, attenuating or exacerbating amyloid-β (Aβ) and tau pathologies in AD, while consistently worsening α-synuclein-induced neurodegeneration in PD. Although CX3CR1 emerges as a promising therapeutic and diagnostic target, its complex role in microglial dynamics remains incompletely understood. Positron emission tomography (PET) imaging provides a powerful, noninvasive method for investigating biological processes in vivo. There is an urgent need to develop and validate new PET tracers targeting microglial CX3CR1 in the CNS, further offering new opportunities for the diagnosis and treatment of neuroinflammation-associated neurodegenerative diseases.
Insights
Microglia
Area of Science:
- Neuroimmunology
- Central Nervous System (CNS) research
- Microglial biology
Background:
- Microglia are key CNS immune cells regulating brain homeostasis.
- CX3CR1 receptor on microglia interacts with CX3CL1, influencing neuroimmune responses.
- CX3CR1-CX3CL1 signaling has complex, context-dependent roles in neurodegenerative diseases like Alzheimer's and Parkinson's.
Purpose of the Study:
- To highlight the complex and incompletely understood role of CX3CR1 in microglial dynamics.
- To emphasize the need for novel Positron Emission Tomography (PET) tracers targeting CX3CR1.
- To explore opportunities for diagnosing and treating neuroinflammation-associated neurodegenerative diseases.
Main Methods:
- Review of existing literature on CX3CR1 function in neurodegeneration models.
- Discussion of the potential of Positron Emission Tomography (PET) for in vivo imaging of microglial CX3CR1.
- Identification of the need for developing and validating new PET tracers.
Main Results:
- CX3CR1 deficiency yields paradoxical outcomes in Alzheimer's and Parkinson's disease models.
- CX3CR1 is a promising, yet complex, therapeutic and diagnostic target.
- PET imaging offers a noninvasive approach to study in vivo microglial CX3CR1 dynamics.
Conclusions:
- Developing novel PET tracers for microglial CX3CR1 is crucial.
- Such tracers could advance diagnosis and treatment strategies for neuroinflammatory diseases.
- Further research into CX3CR1's role is essential for understanding and combating neurodegeneration.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
06:19In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy
Published on: November 11, 2017
